Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells

Blood

Volumn 99, Issue 2, 2002, Pages 399-408

  Cui, Yan ^a   Golob, Jonathan ^a   Kelleher, Erin ^a   Ye, Zhaohui ^a   Pardoll, Drew ^a   Cheng, Linzhao ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; GREEN FLUORESCENT PROTEIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD DISEASE; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DIABETES MELLITUS; DNA MODIFICATION; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; GENETIC STABILITY; HEMATOPOIETIC STEM CELL; HOUSEKEEPING GENE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LENTIVIRINAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCID MOUSE; T LYMPHOCYTE ACTIVATION;

EID: 0037079725     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.2.399     Document Type: Article

References (54)

1. Gene transfer to hematopoietic stem cells: Implications for gene therapy of human disease
2. Stem cell directed gene therapy
3. Gene therapy using hemato-poietic stem cells: Sisyphus approaches the crest
4. Hematopoietic stem cell gene therapy: Towards clinically significant gene transfer efficiency
5. Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease
6. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
7. Use of retroviral vectors for gene transfer and expression
8. The basic science of gene therapy
9. Therapeutic potential of retroviral vectors
10. Progress in transcriptionally targeted and regulatable vectors for genetic therapy
11. Sustained gene expression in retrovirally transduced, engrafting human hematopoietic stem cells and their lympho-myeloid progeny
12. + cells expands progenitor cell numbers, preserves engraftment capacity in NOD/SCID mice, and enhances retroviral transduction efficiency
13. Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: Dissociation of SRC phenotype and function
14. High-efficiency retroviral transduction of mammalian cells on positively charged surfaces
15. Efficient retrovirus-mediated gene transfer to transplantable human BM cells in the absence of fibronectin
16. Distinct classes of human stem cells differ in proliferative and self-renewal potential
17. Infectivity and methylation of retroviral genomes is correlated with expression in the animal
18. Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo
19. Long-term silencing of retroviral vectors is resistant to reversal by trichostatin A and 5-azacytidine
20. Inactivation of a GFP retrovirus occurs at multiple levels in long-term repopulating stem cells and their differentiated progeny
21. Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism
22. Transcriptional interference and termination between duplicated α-globin gene constructs suggests a novel mechanism for gene regulation
23. A GFP reporter system to assess gene transfer and expression in viable human hematopoietic progenitor cells
24. Transcriptional targeting of retroviral vectors to the erythroblastic progeny of transduced hematopoietic stem cells
25. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells
26. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
27. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors
28. Human cord blood CD34+CD38- cell transduction via lentivirus-based gene transfer vectors
29. Transduction of human CD34+ CD38- bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors
30. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors
31. Lentiviral vectors: Turning a deadly foe into a therapeutic agent
32. Lentiviral gene transfer into primary and secondary NOD/SCID repopulating cells
33. Lentiviral vectors for enhanced gene expression in human hematopoietic cells
34. High levels of transgene expression following long-term NOD/SCID repopulating human cells with a modified lentiviral vectors
35. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo
36. Contributions of viral splice sites and cis-regulatory elements to lentivirus vector function
37. Development of a self-inactivating lentivirus vector
38. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
39. Self-inactivating lentiviral vectors with U3 and U5 modifications
40. Dendritic cells and the control of immunity
41. Dendritic cells in cancer immunotherapy
42. Dynamics of T lymphocyte responses: Intermediates, effectors, and memory cells
43. Dendritic cell vaccines for cancer immunotherapy
44. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin
45. Organization of the transcriptional unit of a human class II histocompatibility antigen: HLA-DR heavy chain
46. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector
47. Production and concentration of pseudotyped HIV-1-based gene transfer vectors
48. Functional differences between subpopulations of mobilized peripheral blood-derived CD34+ cells expressing different levels of HLA-DR, CD33, CD38 and c-kit antigens
49. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood
50. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras
51. Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood
52. Human hematopoietic stem/progenitor cells generate CD5+ B lymphoid cells in NOD/SCID mice
53. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells
54. Arrest of human dendritic cells at the CD34-/CD4+/HLA-DR+ stage in the bone marrow of NOD/SCID-human chimeric mice